The 13th Annual 2025 Immuno-Oncology Summit showcases successes in preclinical and clinical studies grounded in a deep understanding of biology. Coverage spans solid tumor innovations, including bi/multispecific antibodies, antibody-drug conjugates (ADCs), allogenic and in vivo CAR-Ts , TILs, TCRs, Tregs, multiple cell therapies working together, the tumor microenvironment, innate immunity , gamma delta T cells, NK cells , organoid modeling, data science, and machine learning . The program also
Monday, August 11, 2025 - Wednesday, August 13, 2025
Philadelphia, USA
The 13th Annual 2025 Immuno-Oncology Summit showcases successes in preclinical and clinical studies grounded in a deep understanding of biology. Coverage spans solid tumor innovations, including bi/multispecific antibodies, antibody-drug conjugates (ADCs), allogenic and in vivo CAR-Ts , TILs, TCRs, Tregs, multiple cell therapies working together, the tumor microenvironment, innate immunity , gamma delta T cells, NK cells , organoid modeling, data science, and machine learning . The program also
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox